Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption

Anne Sophie Sølling*, Torben Harsløf, Niklas Rye Jørgensen, Bente Langdahl

*Corresponding author for this work
2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption'. Together they form a unique fingerprint.

Medicine & Life Sciences